Metraipolis › archive › dc_a1010f41f4cf

Haploidentical HSCT vs immunosuppressive therapy for severe aplastic anemia in patients aged 40-65 years: a retrospective comparative study — Europe PMC PMID:42821361

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42821361
DOI
10.1093/stcltm/szag076
License (as archived)
solo-consultazione
Archived
2026-10-16T13:06:28.407Z
SHA-256 of the archived text
c564e9e2c237a143e3d3c54eaa1f0f9383609567c119fb580023f215d10f0e77
Stable URL of this page
https://metraipolis.com/documento/dc_a1010f41f4cf

How to cite

Haploidentical HSCT vs immunosuppressive therapy for severe aplastic anemia in patients aged 40-65 years: a retrospective comparative study — Europe PMC PMID:42821361 — Europe PMC (en), https://europepmc.org/article/MED/42821361 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_a1010f41f4cf (Metraipolis archive dc_a1010f41f4cf, sha256 c564e9e2c237a143e3d3c54eaa1f0f9383609567c119fb580023f215d10f0e77)
BibTeX
@misc{dca1010f41f4cf,
  title = {Haploidentical HSCT vs immunosuppressive therapy for severe aplastic anemia in patients aged 40-65 years: a retrospective comparative study — Europe PMC PMID:42821361},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42821361},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_a1010f41f4cf; sha256 c564e9e2c237a143e3d3c54eaa1f0f9383609567c119fb580023f215d10f0e77},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42821361. Agents can read the archived copy with the MCP tool read_document.